Mumbai-based health tech startup Cognota Healthcare has announced that the United States Food and Drug Administration (US FDA) has approved the company’s blood pressure monitor device- ‘COGNOHEALTH Blood Pressure Monitor’, marking the successful foray of the company into the medical devices segment.

The regulatory approval is a significant milestone for Cognota which can now export its blood pressure monitor devices to the US, Europe, and other overseas countries along with tapping the burgeoning Indian market.

The ‘COGNOHEALTH Blood Pressure Monitor’ device is powered by state-of-the-art technology that has been designed and developed by experts in Cognota’s R&D team. Approval from the US FDA, one of the apex healthcare regulatory bodies of the world, enables Cognota to expand its existing portfolio of health tech solutions that include Remote Patient Monitoring (RPM), Teleconsultation Platform, and Smart ICU among others.